Amneal announced the recent launch of four new products:
- Tobramycin Inhalation Solution, the generic version of Novartis‘ Tobi
- Memantine HCl Immediate Release Tablets 5mg and 10mg, the generic version of Forest’s Namenda
- Temozolomide Capsules 5mg, 20mg, 100mg, 140mg, 180mg, 250mg, the generic version of Merck’s Temodar
- Divalproex Sodium Extended Release Tablets 250mg and 500mg, the generic version of AbbVie’s Depakote ER
Tobramycin Inhalation Solution is an aminoglycoside antibiotic indicated for the management of cystic fibrosis in patients with Pseudomonas aeruginosa. Memantine HCl is an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for moderate-to-severe dementia of the Alzheimer’s type. Temozolomide is an alkylating agent indicated for the treatment of newly diagnosed glioblastoma multiforme and refractory anaplastic astrocytoma. Divalproex Sodium is an antiepileptic indicated for the prophylaxis of migraine headaches, for acute manic or mixed episodes in bipolar disorder, for absence seizures, and complex partial seizures.
For more information call (877) 835-5472 or visit Amneal.com.